Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus

NACompletedINTERVENTIONAL
Enrollment

143

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2019

Conditions
Lupus Erythematosus
Interventions
OTHER

GADD34 RNA level measurement.

"Blood analysis including GADD34 RNA level measurement is performed every 3 months up to 1 year for SLE patients.~A modal including physical exam, standard biological results and GADD34 RNA level is correlated to a SLE flare occurence in the next 3 months."

Trial Locations (7)

13003

Hopital européen de Marseille, Marseille

13005

CHU Marseille, Marseille

38000

CHU Grenoble, Grenoble

groupement hospitalier mutualiste de Grenoble, Grenoble

42000

CHU Saint Etienne, Saint-Etienne

69310

CHU Lyon sud, Pierre-Bénite

74370

CHR Annecy Genevois, Metz-Tessy

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT02455089 - Prognosis Assessment of the Increase of GADD34 Gene Expression for Patient Suffering From Systemic Lupus Erythematosus | Biotech Hunter | Biotech Hunter